ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exploring ibuprofen derivatives as α-glucosidase and lipoxygenase inhibitors: Cytotoxicity and in silico studies

Daud, Saima; Abid, Obaid-ur-Rahman*; Sardar, Asma; Abdullah, Shawana; Shahid, Wardah; Ashraf, Muhammad*; Ejaz, Syeda Abida; Saeed, Amna; Shah, Basit Ali; Niaz, Basit*
Archiv der Pharmazie2022-8DOI: 10.1002/ardp.202200013
4被引6阅读
引用收藏
分享

摘要

This study reports the synthesis of a series of ibuprofen derivatives, including thiosemicarbazides 4a-f, 1,3,4-oxadiazoles 5a-f, 1,3,4-thiadiazoles 6a-f, 1,2,4-triazoles 7a-f, and their S-alkylated derivatives 8a-d. All of the newly synthesized derivatives were analyzed using H-1 NMR, C-13 NMR spectroscopy, and high-resolution mass spectra (electron ionization) spectrometry. These synthetic molecules were examined for their in vitro baking yeast alpha-glucosidase and soybean 15-lipoxygenase (15-LOX) inhibition and cell viability studies. The results revealed that the compounds N-(3,4-dichlorophenyl)-5-[1-(4-isobutylphenyl)ethyl]-1,3,4-oxadiazol-2-amine 5f (IC50 3.05 +/- 1.23 mu M) and N-(3-fluorophenyl)-5-[1-(4-isobutylphenyl)ethyl]-1,3,4-oxadiazol-2-amine 5b (IC50 3.12 +/- 1.21 mu M) were the most potent with respect to the alpha-glucosidase enzyme while in case of 15-LOX, the compound 4-(2,4-dichlorophenyl)-1-[2-(4-isobutylphenyl)propanoyl]thiosemicarbazide 4e showed potent inhibition with an IC50 value of 55.41 +/- 0.41 mu M. All these compounds were found least toxic by displaying a blood mononuclear cell viability value of 69.2%-97.8% by the MTT assay compared to the standards when assayed at 0.25 mM concentration. Molecular docking analyses were conducted to evaluate the inhibition profiles of these derivatives against the said enzymes and the data supported the in vitro profiles.

学科与关键词

关键词
15-LOX inhibitionalpha-glucosidase inhibitionazole derivativesibuprofenmolecular docking
相关
加载中…
  • Design, synthesis, in vitro evaluation, and docking studies on ibuprofen derived 1,3,4-oxadiazole derivatives as dual α-glucosidase and urease inhibitors
    Daud, Saima; Abid, Obaid-ur-Rahman*; Sardar, Asma; Shah, Basit Ali; Rafiq, Muhammad; Wadood, Abdul; Ghufran, Mehreen; Rehman, Wajid; Zain-ul-Wahab; Iftikhar, Fatima; Sultana, Rifhat; Daud, Habiba; Niaz, Basit*MEDICINAL CHEMISTRY RESEARCH, 2022, 31(2): 316-336.被引 16
  • In vitro evaluation of novel mefenamic acid derivatives as potential a-glucosidase and urease inhibitors: Design, synthesis, in silico and cytotoxic studies
    Daud, Saima; Abid, Obaid-ur-Rahman*; Rehman, Wajid*; Niaz, Maryam; Sardar, Asma; Rasheed, Liaqat; Niaz, Basit; Shah, Basit Ali; Alotaibi, Hadil Faris; Obaidullah, Ahmad J.; Alanazi, Mohammed M.Journal of Saudi Chemical Society, 2023, 27(4): 101680.
  • Identification of novel diclofenac acid and naproxen bearing hydrazones as 15-LOX inhibitors: Design, synthesis, in vitro evaluation, cytotoxicity, and in silico studies
    Sardar, Asma; Abid, Obaid-ur-Rahman*; Daud, Saima; Shah, Basit Ali; Shahid, Wardah; Ashraf, Muhammad; Fatima, Mahvish; Ezzine, Safa; Wadood, Abdul; Shareef, Azam; Al-Ghulikah, Hanan A.; Alissa, Siham A.Arabian Journal of Chemistry, 2022, 15(12): 104300.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Archiv der Pharmazie
发表日期
2022-08
卷期
第 355 卷, 第 8 期
页码
e2200013
DOI
10.1002/ardp.202200013
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Higher Education Commission, Pakistan [4950]

作者

  • D

    Daud, Saima (第一作者)

  • A

    Abid, Obaid-ur-Rahman (通讯)

查看全部 10 位作者收起作者
  • S

    Sardar, Asma

  • A

    Abdullah, Shawana

  • S

    Shahid, Wardah

  • A

    Ashraf, Muhammad (通讯)

  • E

    Ejaz, Syeda Abida

  • S

    Saeed, Amna

  • S

    Shah, Basit Ali

  • N

    Niaz, Basit (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417